The A3 Adenosine Receptor as a New Target for Cancer Therapy and Chemoprotection

Author： Fishman P. Bar-Yehuda S. Barer F. Madi L. Multani A.S. Pathak S.

Publisher： Elsevier

ISSN： 0014-4827

Source： Experimental Cell Research, Vol.269, Iss.2, 2001-10, pp. : 230-236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CCN6 (WISP3): a new anti-cancer therapy?

By Leask Andrew

Journal of Cell Communication and Signaling, Vol. 4, Iss. 4, 2010-12 ,pp. : 199-200

Springer Publishing Company

Access to resources Recommend Favorite

A 2B adenosine receptor blockade inhibits growth of prostate cancer cells

By Wei Qiang

Purinergic Signalling, Vol. 9, Iss. 2, 2013-06 ,pp. : 271-280

Springer Publishing Company

Access to resources Recommend Favorite

Induction of Apoptosis in Cardiac Myocytes by an A 3 Adenosine Receptor Agonist

By Shneyvays V. Nawrath H. Jacobson K.A. Shainberg A.

Experimental Cell Research, Vol. 243, Iss. 2, 1998-09 ,pp. : 383-397

Elsevier

Access to resources Recommend Favorite

p53: Emergency Brake and Target for Cancer Therapy

By Wiman K.G.

Experimental Cell Research, Vol. 237, Iss. 1, 1997-11 ,pp. : 14-18

Elsevier

Access to resources Recommend Favorite

Characterization of the Mouse A3 Adenosine Receptor Gene: Exon/Intron Organization and Promoter Activity

By Zhao Z. Francis C. Ravid K.

Genomics, Vol. 57, Iss. 1, 1999-04 ,pp. : 152-155

Elsevier

Access to resources Recommend Favorite